Table 1:
Descriptive Characteristics of All Births and Notifications by Single and Polysubstance Exposure, Connecticut, March 15, 2019 – August 22, 2022 (n = 6,850)
| All Births (n = 115352) |
All notifications (n = 6850) |
Single Substance (n =5760) |
Polysubstance (n =1090) |
|||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Mean or N |
SD or % |
Mean or N |
SD or % |
Mean or N |
SD or % |
Mean or N |
SD or % |
|
| Maternal Age*** | 31.19 | 5.53 | 28.09 | 5.79 | 27.63 | 5.75 | 30.52 | 5.35 |
| Maternal Race/Ethnicity | ||||||||
| White*** | 61716 | 53.5% | 2980 | 43.5% | 2302 | 40% | 678 | 62.2% |
| Black*** | 15161 | 13.1% | 1435 | 21.0% | 1303 | 22.6% | 132 | 12.1% |
| Hispanic*** | 30918 | 26.8% | 1424 | 20.8% | 1299 | 22.6% | 125 | 11.5% |
| Other/Multi-race | 7478 | 6.5% | 79 | 1.2% | 71 | 1.2% | 8 | 0.7% |
| Declined/Not disclosed | 79 | 0.07% | 932 | 13.6% | 785 | 13.6% | 147 | 13.5% |
| Number of Substances*** | - | 1.22 | .57 | 1 | 0 | 2.39 | .65 | |
| Exposure Type | ||||||||
| Alcohol*** | - | 200 | 2.9% | 63 | 1.1% | 137 | 12.6% | |
| Cannabis*** | - | 5451 | 79.6% | 4798 | 83.3% | 653 | 59.9% | |
| Cocaine*** | - | 567 | 8.3% | 114 | 2.0% | 453 | 41.6% | |
| PCP*** | - | 83 | 1.2% | 28 | .5% | 55 | 5.1% | |
| Rx benzodiazepine*** | - | 175 | 2.6% | 65 | 1.1% | 110 | 10.1% | |
| Rx opiates*** | - | 616 | 9.0% | 211 | 3.7% | 405 | 37.2% | |
| NonRx opiates*** | - | 436 | 6.4% | 114 | 2.0% | 322 | 29.6% | |
| Misuse*** | - | 22 | 0.3% | 8 | .1% | 14 | 1.3% | |
| Other illegal*** | - | 295 | 4.3% | 52 | .9% | 243 | 22.3% | |
| Buprenorphine*** | - | 353 | 5.2% | 195 | 3.4% | 158 | 14.5% | |
| Methadone*** | - | 607 | 8.9% | 226 | 3.9% | 381 | 35.0% | |
| Type of Infant Toxicology | ||||||||
| Meconium | - | 492 | 7.2% | 401 | 7.0% | 91 | 8.4% | |
| Meconium, Umbilical Cord, & Urine | - | 22 | 0.3% | 16 | .3% | 6 | .6% | |
| Meconium & Urine*** | - | 2522 | 36.8% | 2130 | 37.0% | 392 | 36.0% | |
| Umbilical Cord*** | - | 271 | 4.0% | 194 | 3.4% | 77 | 7.1% | |
| Urine | - | 1483 | 21.7% | 1234 | 21.4% | 249 | 22.8% | |
| Urine & Umbilical Cord*** | - | 99 | 1.5% | 66 | 1.2% | 33 | 3.0% | |
| Others | - | 51 | 0.7% | 43 | 0.8% | 8 | 0.7% | |
| Infant Not Tested | - | 1910 | 27.9% | 1676 | 29.1% | 234 | 21.5% | |
| Positive Infant Toxicology at Time of Notification | 696 | 10.2% | 509 | 8.8% | 187 | 17.2% | ||
| FCP type | ||||||||
| No FCP*** | - | 2192 | 32.0% | 1671 | 29.0% | 521 | 47.8% | |
| Prenatal | - | 1845 | 26.9% | 1534 | 26.6% | 311 | 28.5% | |
| Postnatal*** | - | 2813 | 41.1% | 2555 | 44.4% | 258 | 23.7% | |
| Safety Concern*** | - | 2353 | 34.4% | 1595 | 27.7% | 758 | 69.5% | |
Notes. FCP = family care plan. The racial categories used in the notification have been collapsed into the noted mutually exclusive categories. The substance exposure categories reflect single substance exposures or “polysubstance”, which includes any combination of two or more substances.
*
p < .05
**
p < .01
***
p < .001